Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 18 studies | 40% ± 22% | |
| peripheral blood | 16 studies | 29% ± 9% | |
| lung | 13 studies | 25% ± 9% | |
| eye | 8 studies | 28% ± 12% | |
| kidney | 7 studies | 21% ± 3% | |
| liver | 6 studies | 28% ± 12% | |
| bone marrow | 4 studies | 31% ± 12% | |
| heart | 4 studies | 30% ± 8% | |
| uterus | 4 studies | 23% ± 7% | |
| lymph node | 4 studies | 20% ± 3% | |
| adipose | 4 studies | 30% ± 5% | |
| intestine | 3 studies | 21% ± 7% | |
| breast | 3 studies | 20% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2967.66 | 1445 / 1445 | 100% | 36.46 | 183 / 183 |
| lung | 100% | 4928.15 | 577 / 578 | 100% | 28.86 | 1152 / 1155 |
| brain | 99% | 2972.89 | 2627 / 2642 | 100% | 33.21 | 705 / 705 |
| breast | 100% | 4057.72 | 459 / 459 | 98% | 38.90 | 1099 / 1118 |
| thymus | 100% | 2587.69 | 652 / 653 | 98% | 18.83 | 590 / 605 |
| kidney | 100% | 2400.89 | 89 / 89 | 97% | 29.80 | 874 / 901 |
| ovary | 100% | 2334.74 | 180 / 180 | 97% | 13.33 | 417 / 430 |
| prostate | 100% | 2313.56 | 244 / 245 | 96% | 20.72 | 480 / 502 |
| uterus | 100% | 3395.84 | 170 / 170 | 95% | 20.74 | 437 / 459 |
| stomach | 99% | 1765.93 | 357 / 359 | 95% | 23.78 | 273 / 286 |
| intestine | 100% | 2415.90 | 962 / 966 | 95% | 19.77 | 502 / 527 |
| bladder | 100% | 2687.76 | 21 / 21 | 95% | 19.06 | 478 / 504 |
| adrenal gland | 100% | 2257.28 | 258 / 258 | 93% | 17.75 | 215 / 230 |
| pancreas | 94% | 1265.76 | 308 / 328 | 98% | 22.42 | 174 / 178 |
| skin | 100% | 5366.16 | 1809 / 1809 | 92% | 30.15 | 432 / 472 |
| liver | 96% | 1188.17 | 217 / 226 | 69% | 8.19 | 281 / 406 |
| blood vessel | 100% | 3690.67 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2983.18 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 25.14 | 45 / 45 |
| adipose | 100% | 4441.06 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 19.69 | 28 / 29 |
| muscle | 97% | 2110.64 | 775 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 94% | 4333.76 | 877 / 929 | 0% | 0 | 0 / 0 |
| heart | 93% | 1495.99 | 801 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 79% | 17.91 | 63 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0036150 | Biological process | phosphatidylserine acyl-chain remodeling |
| GO_0046326 | Biological process | positive regulation of glucose import |
| GO_0015914 | Biological process | phospholipid transport |
| GO_0120009 | Biological process | intermembrane lipid transfer |
| GO_0010891 | Biological process | negative regulation of sequestering of triglyceride |
| GO_0046628 | Biological process | positive regulation of insulin receptor signaling pathway |
| GO_0090204 | Biological process | protein localization to nuclear pore |
| GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
| GO_0030336 | Biological process | negative regulation of cell migration |
| GO_0045444 | Biological process | fat cell differentiation |
| GO_0032541 | Cellular component | cortical endoplasmic reticulum |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005829 | Cellular component | cytosol |
| GO_0031965 | Cellular component | nuclear membrane |
| GO_0140343 | Molecular function | phosphatidylserine transfer activity |
| GO_0015485 | Molecular function | cholesterol binding |
| GO_0001786 | Molecular function | phosphatidylserine binding |
| GO_0005548 | Molecular function | phospholipid transporter activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0070273 | Molecular function | phosphatidylinositol-4-phosphate binding |
| Gene name | OSBPL8 |
| Protein name | Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8) Alternative protein OSBPL8 OSBPL8 protein Oxysterol-binding protein Oxysterol binding protein like 8 |
| Synonyms | OSBP10 ORP8 KIAA1451 |
| Description | FUNCTION: Lipid transporter involved in lipid countertransport between the endoplasmic reticulum and the plasma membrane: specifically exchanges phosphatidylserine with phosphatidylinositol 4-phosphate (PI4P), delivering phosphatidylserine to the plasma membrane in exchange for PI4P, which is degraded by the SAC1/SACM1L phosphatase in the endoplasmic reticulum. Binds phosphatidylserine and PI4P in a mutually exclusive manner . Binds oxysterol, 25-hydroxycholesterol and cholesterol . . |
| Accessions | ENST00000549570.5 F8VZB8 ENST00000547540.5 F8VUA7 F8W1F1 ENST00000393250.8 [Q9BZF1-3] ENST00000611266.4 [Q9BZF1-3] Q96E43 Q9BZF1 ENST00000547544.5 ENST00000549646.5 ENST00000553139.5 F8VVE7 F8VVD3 L8ECJ0 F8VS33 ENST00000393249.6 [Q9BZF1-3] ENST00000546946.5 F8W060 ENST00000548341.5 ENST00000550628.5 F8VZ43 ENST00000261183.8 [Q9BZF1-1] ENST00000551927.5 F8VQX7 Q641R2 |